(The following press release from Bayer was received by e-mail. It was not confirmed by the sender.) Dear Newsletter Subscriber, The following news item has been released: Bayer CropScience on the announcement by the EU Commission: Restrictions in use of neonicotinoid-containing products is a set-back for European agriculture Commission’s plan will not have a positive impact on bee health Monheim, April 29, 2013 - Bayer CropScience considers the decision by the Commission of the European Union to restrict the use of neonicotinoid-containing products across Europe as a set-back for technology, innovation and sustainability. In an Appeals Committee meeting today, only half of the EU Member States supported the Commission’s proposal for the restrictions. The company believes that the plan by the Commission will not have a positive impact on bee health. The company is concerned that the restriction of these neonicotinoids will result in crop yield losses, reduced food quality and loss of competitiveness for European agriculture. This will have a negative impact on farmers, R&D driven ag companies, the seed industry and the food value chain. As a science-based company, Bayer CropScience is disappointed that clear scientific evidence has taken a back-seat in the decision making process. This disproportionate decision is a missed opportunity to reach a solution that takes into consideration all of the existing product stewardship measures and broad stakeholder concerns. The further reduction of effective crop protection products will put at risk farmers’ ability to tackle important pests that can severely restrict their ability to grow high-quality food. Bayer CropScience remains convinced that neonicotinoids are safe for bees, when used responsibly and properly, according to label instructions. The company will work together with all relevant stakeholders and authorities in the Member States to handle the complex consequences of this decision, to further support its customers. About Bayer CropScience Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission "Bayer: Science For A Better Life". Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: http://www.press.bayercropscience.com. Find more information at http://www.bayercropscience.com. More information on the Bayer Bee Care program can be found at http://www.beecare.bayer.com. Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. This press release is available here: http://www.baynews.bayer.de/baynews/baynews.nsf/id/2013-0252-e Yours BayNews Editorial Team Bayer AG Communications Building W11 51368 Leverkusen, Germany --------------------------------------------------- Further news releases you can find here: http://www.press.bayer.com N.B. This is an automatically generated e-mail which you cannot reply to. If you have any questions, please send us an e-mail via our contact form: https://secure.bayer.com/bayer/contact.aspx?lang=en You can cancel your subscription to the BayNews-Newsletter or change your personal settings at any time by going to https://ssl.bayer.com/baynews/baynews.nsf/id/EN_userprofile?open To ensure receipt, please add email@example.com to your address book or list of trusted senders. --------------------------------------------------- © Bayer AG, 51368 Leverkusen, Germany. All rights reserved. The entire contents, including images, graphics, animations etc., of this e-mail and the server http://www.bayer.com are copyrighted. Board of Management: Marijn Dekkers, Chairman | Werner Baumann, Michael König, Wolfgang Plischke, Richard Pott Chairman of the Supervisory Board: Werner Wenning Registered office: Leverkusen | Local Court of Cologne, HRB 48248
Japan Unexpectedly Targets Bigger Expansion of Monetary Base; Yen Drops; Nikkei 225 Surges
BAYER: NEONICOTINOID-PRODUCTS SAFE FOR BEES WITHIN LABEL (ENG)
Press spacebar to pause and continue. Press esc to stop.